# Ovid Therapeutics Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:0b05be43-c1e7-40d4-a121-a3987ede577d | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/ovid-therapeutics-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 25 | | Claims under review | 1 | | Evidence records | 4 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-16T04:46:26.520291+00:00 | | Last reviewed | 2026-10-16T04:46:26.520291+00:00 | ## Identity - Legal name: Ovid Therapeutics Inc. - Display name: Ovid Therapeutics Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-16T09:25:47.834737+00:00 | | Completeness | 0.409 | | Record Quality | 0.823 | | Directors | 10 | | Committees | 4 | | Governance events | 5 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Barbara Duncan: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2017-01-01. claim_id=alpha:claim:company:0b05be43-c1e7-40d4-a121-a3987ede577d:leadership_role:6 - Bart Friedman: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2015-01-01. Committees: Audit Committee (member); Compensation Committee (member); Nominating and Corporate Governance Committee (chair). claim_id=alpha:claim:company:0b05be43-c1e7-40d4-a121-a3987ede577d:leadership_role:7 - Jeffrey Rona: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-04-27. claim_id=alpha:claim:company:0b05be43-c1e7-40d4-a121-a3987ede577d:leadership_role:9 - Kevin Fitzgerald: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2021-01-01. Committees: Nominating and Corporate Governance Committee (member). claim_id=alpha:claim:company:0b05be43-c1e7-40d4-a121-a3987ede577d:leadership_role:10 - Stelios Papadopoulos: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2025-01-01. Committees: Audit Committee (member); Compensation Committee (member). claim_id=alpha:claim:company:0b05be43-c1e7-40d4-a121-a3987ede577d:leadership_role:13 - Bart Friedman, JD: Lead Independent Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:0b05be43-c1e7-40d4-a121-a3987ede577d:leadership_role:8 - Jeremy M. Levin, DPhil, MB BChir: Executive Chairman of the Board. Status: unknown. Independent: false. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:0b05be43-c1e7-40d4-a121-a3987ede577d:leadership_role:5 - Kevin Fitzgerald, PhD: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:0b05be43-c1e7-40d4-a121-a3987ede577d:leadership_role:11 - Margaret Alexander: Director, President and Chief Executive Officer. Status: unknown. Independent: false. Since: NOT_PUBLISHED. Committees: President and Chief Executive Officer (member). claim_id=alpha:claim:company:0b05be43-c1e7-40d4-a121-a3987ede577d:leadership_role:12 - Stelios Papadopoulos, PhD: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:0b05be43-c1e7-40d4-a121-a3987ede577d:leadership_role:14 ## Committees - Audit Committee (audit). Chair: NOT_PUBLISHED. Members: Bart Friedman (member, current); Stelios Papadopoulos (member, current). committee_id=alpha:committee:ovid-therapeutics-inc:audit-committee - Compensation Committee (compensation). Chair: NOT_PUBLISHED. Members: Bart Friedman (member, current); Stelios Papadopoulos (member, current). committee_id=alpha:committee:ovid-therapeutics-inc:compensation-committee - Nominating and Corporate Governance Committee (nominating_governance). Chair: Bart Friedman. Members: Bart Friedman (chair, current); Kevin Fitzgerald (member, current). committee_id=alpha:committee:ovid-therapeutics-inc:nominating-and-corporate-governance-committee - President and Chief Executive Officer (executive). Chair: NOT_PUBLISHED. Members: Margaret Alexander (member, unknown). committee_id=alpha:committee:ovid-therapeutics-inc:president-and-chief-executive-officer ## Executive leadership - Jeffrey Rona: Chief Business and Financial Officer. Status: unknown. claim_id=alpha:claim:company:0b05be43-c1e7-40d4-a121-a3987ede577d:leadership_role:15 - Margaret Alexander: President and Chief Executive Officer [CEO]. Status: unknown. claim_id=alpha:claim:company:0b05be43-c1e7-40d4-a121-a3987ede577d:leadership_role:16 ## Governance events - DIRECTOR_APPOINTED: Jeffrey Rona seat on Ovid Therapeutics Inc., effective 2026-04-27. Effective: 2026-04-27. Detected: 2026-10-16T04:46:26.520291+00:00. event_id=alpha:event:transition:axalzo1peh9eu - DIRECTOR_APPOINTED: Stelios Papadopoulos seat on Ovid Therapeutics Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-16T04:46:26.520291+00:00. event_id=alpha:event:transition:yvor2f107eukz - DIRECTOR_APPOINTED: Kevin Fitzgerald seat on Ovid Therapeutics Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T04:46:26.520291+00:00. event_id=alpha:event:transition:63o3vc1w3fn5o - DIRECTOR_APPOINTED: Barbara Duncan seat on Ovid Therapeutics Inc., effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-16T04:46:26.520291+00:00. event_id=alpha:event:transition:1k3pbq61w06u4u - DIRECTOR_APPOINTED: Bart Friedman seat on Ovid Therapeutics Inc., effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-16T04:46:26.520291+00:00. event_id=alpha:event:transition:1253m4315sqy81 ## Scoped resources - `alpha://company/ovid-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/ovid-therapeutics-inc?format=record - `alpha://company/ovid-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/ovid-therapeutics-inc?format=record§ion=identity - `alpha://company/ovid-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/ovid-therapeutics-inc?format=record§ion=corporate-structure - `alpha://company/ovid-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/ovid-therapeutics-inc?format=record§ion=board - `alpha://company/ovid-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/ovid-therapeutics-inc?format=record§ion=committees - `alpha://company/ovid-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/ovid-therapeutics-inc?format=record§ion=leadership - `alpha://company/ovid-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/ovid-therapeutics-inc?format=record§ion=ownership - `alpha://company/ovid-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/ovid-therapeutics-inc?format=record§ion=financials - `alpha://company/ovid-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/ovid-therapeutics-inc?format=record§ion=capital-structure - `alpha://company/ovid-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/ovid-therapeutics-inc?format=record§ion=compensation - `alpha://company/ovid-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/ovid-therapeutics-inc?format=record§ion=governance - `alpha://company/ovid-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/ovid-therapeutics-inc?format=record§ion=shareholder-governance - `alpha://company/ovid-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/ovid-therapeutics-inc?format=record§ion=audit - `alpha://company/ovid-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/ovid-therapeutics-inc?format=record§ion=legal - `alpha://company/ovid-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/ovid-therapeutics-inc?format=record§ion=risk - `alpha://company/ovid-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/ovid-therapeutics-inc?format=record§ion=cyber - `alpha://company/ovid-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/ovid-therapeutics-inc?format=record§ion=ai-governance - `alpha://company/ovid-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/ovid-therapeutics-inc?format=record§ion=agents - `alpha://company/ovid-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/ovid-therapeutics-inc?format=record§ion=ecosystem - `alpha://company/ovid-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/ovid-therapeutics-inc?format=record§ion=events - `alpha://company/ovid-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/ovid-therapeutics-inc?format=record§ion=relationships - `alpha://company/ovid-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/ovid-therapeutics-inc?format=record§ion=assessments - `alpha://company/ovid-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/ovid-therapeutics-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:0b05be43-c1e7-40d4-a121-a3987ede577d:committee_appointment:18: `{"kind":"committee_appointment","original_name":"Audit Committee","category":"audit","role":"member","person":{"alpha_id":"alpha:person:bart-friedman-ovid","name":"Bart Friedman"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:0b05be43-c1e7-40d4-a121-a3987ede577d:committee_appointment:19: `{"kind":"committee_appointment","original_name":"Audit Committee","category":"audit","role":"member","person":{"alpha_id":"alpha:person:stelios-papadopoulos-ovid","name":"Stelios Papadopoulos"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:0b05be43-c1e7-40d4-a121-a3987ede577d:committee_appointment:21: `{"kind":"committee_appointment","original_name":"Compensation Committee","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:bart-friedman-ovid","name":"Bart Friedman"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:0b05be43-c1e7-40d4-a121-a3987ede577d:committee_appointment:22: `{"kind":"committee_appointment","original_name":"Compensation Committee","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:stelios-papadopoulos-ovid","name":"Stelios Papadopoulos"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:0b05be43-c1e7-40d4-a121-a3987ede577d:committee_appointment:24: `{"kind":"committee_appointment","original_name":"Nominating and Corporate Governance Committee","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:bart-friedman-ovid","name":"Bart Friedman"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:0b05be43-c1e7-40d4-a121-a3987ede577d:committee_appointment:25: `{"kind":"committee_appointment","original_name":"Nominating and Corporate Governance Committee","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:kevin-fitzgerald-ovid","name":"Kevin Fitzgerald"},"source_id":"governance_people_committees"}` ## Leadership - Jeremy M. Levin, DPhil, MB BChir: Executive Chairman of the Board. Claim: alpha:claim:company:0b05be43-c1e7-40d4-a121-a3987ede577d:leadership_role:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8df87dfa11d4b772a1feb4e92d0f8850aa4452ce8665367bfe06a0d3b7b76c52. - Barbara Duncan: Director. Claim: alpha:claim:company:0b05be43-c1e7-40d4-a121-a3987ede577d:leadership_role:6. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c85694de3ded3b66156d1756d8dc0a5c7f7292c72ac71db0f7c22a4adf2c37d6. - Bart Friedman: Director. Claim: alpha:claim:company:0b05be43-c1e7-40d4-a121-a3987ede577d:leadership_role:7. Valid from: 2015-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c85694de3ded3b66156d1756d8dc0a5c7f7292c72ac71db0f7c22a4adf2c37d6. - Bart Friedman, JD: Lead Independent Director. Claim: alpha:claim:company:0b05be43-c1e7-40d4-a121-a3987ede577d:leadership_role:8. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8df87dfa11d4b772a1feb4e92d0f8850aa4452ce8665367bfe06a0d3b7b76c52. - Jeffrey Rona: Director. Claim: alpha:claim:company:0b05be43-c1e7-40d4-a121-a3987ede577d:leadership_role:9. Valid from: 2026-04-27. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c85694de3ded3b66156d1756d8dc0a5c7f7292c72ac71db0f7c22a4adf2c37d6. - Kevin Fitzgerald: Director. Claim: alpha:claim:company:0b05be43-c1e7-40d4-a121-a3987ede577d:leadership_role:10. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c85694de3ded3b66156d1756d8dc0a5c7f7292c72ac71db0f7c22a4adf2c37d6. - Kevin Fitzgerald, PhD: Director. Claim: alpha:claim:company:0b05be43-c1e7-40d4-a121-a3987ede577d:leadership_role:11. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8df87dfa11d4b772a1feb4e92d0f8850aa4452ce8665367bfe06a0d3b7b76c52. - Margaret Alexander: Director, President and Chief Executive Officer. Claim: alpha:claim:company:0b05be43-c1e7-40d4-a121-a3987ede577d:leadership_role:12. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8df87dfa11d4b772a1feb4e92d0f8850aa4452ce8665367bfe06a0d3b7b76c52. - Stelios Papadopoulos: Director. Claim: alpha:claim:company:0b05be43-c1e7-40d4-a121-a3987ede577d:leadership_role:13. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c85694de3ded3b66156d1756d8dc0a5c7f7292c72ac71db0f7c22a4adf2c37d6. - Stelios Papadopoulos, PhD: Director. Claim: alpha:claim:company:0b05be43-c1e7-40d4-a121-a3987ede577d:leadership_role:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8df87dfa11d4b772a1feb4e92d0f8850aa4452ce8665367bfe06a0d3b7b76c52. - Jeffrey Rona: Chief Business and Financial Officer. Claim: alpha:claim:company:0b05be43-c1e7-40d4-a121-a3987ede577d:leadership_role:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8df87dfa11d4b772a1feb4e92d0f8850aa4452ce8665367bfe06a0d3b7b76c52. - Margaret Alexander: President and Chief Executive Officer. Claim: alpha:claim:company:0b05be43-c1e7-40d4-a121-a3987ede577d:leadership_role:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8df87dfa11d4b772a1feb4e92d0f8850aa4452ce8665367bfe06a0d3b7b76c52. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit Committee: Chair not stated; Members Bart Friedman; Stelios Papadopoulos. Claim: alpha:claim:company:0b05be43-c1e7-40d4-a121-a3987ede577d:committee_record:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:1347145573b7699db28a2ab9f8f46f088d9f8c4f96b78888f655eff3d90f6632. - Compensation Committee: Chair not stated; Members Bart Friedman; Stelios Papadopoulos. Claim: alpha:claim:company:0b05be43-c1e7-40d4-a121-a3987ede577d:committee_record:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:1347145573b7699db28a2ab9f8f46f088d9f8c4f96b78888f655eff3d90f6632. - Nominating and Corporate Governance Committee: Chair Bart Friedman; Members Bart Friedman (Chair); Kevin Fitzgerald. Claim: alpha:claim:company:0b05be43-c1e7-40d4-a121-a3987ede577d:committee_record:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:1347145573b7699db28a2ab9f8f46f088d9f8c4f96b78888f655eff3d90f6632. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Ovid Therapeutics Inc.. Claim: alpha:claim:company:0b05be43-c1e7-40d4-a121-a3987ede577d:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:cdbbb5a756987384df1ff64d8fbf70eef56c1183539d4ebc58373c3652c924dd. ## Entity Status - Public listing published. Claim: alpha:claim:company:0b05be43-c1e7-40d4-a121-a3987ede577d:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:cdbbb5a756987384df1ff64d8fbf70eef56c1183539d4ebc58373c3652c924dd. ## Published Fact - US. Claim: alpha:claim:company:0b05be43-c1e7-40d4-a121-a3987ede577d:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:cdbbb5a756987384df1ff64d8fbf70eef56c1183539d4ebc58373c3652c924dd. ## Committee Appointment - Bart Friedman: member, Audit Committee. Claim: alpha:claim:company:0b05be43-c1e7-40d4-a121-a3987ede577d:committee_appointment:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:1347145573b7699db28a2ab9f8f46f088d9f8c4f96b78888f655eff3d90f6632. - Stelios Papadopoulos: member, Audit Committee. Claim: alpha:claim:company:0b05be43-c1e7-40d4-a121-a3987ede577d:committee_appointment:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:1347145573b7699db28a2ab9f8f46f088d9f8c4f96b78888f655eff3d90f6632. - Bart Friedman: member, Compensation Committee. Claim: alpha:claim:company:0b05be43-c1e7-40d4-a121-a3987ede577d:committee_appointment:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:1347145573b7699db28a2ab9f8f46f088d9f8c4f96b78888f655eff3d90f6632. - Stelios Papadopoulos: member, Compensation Committee. Claim: alpha:claim:company:0b05be43-c1e7-40d4-a121-a3987ede577d:committee_appointment:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:1347145573b7699db28a2ab9f8f46f088d9f8c4f96b78888f655eff3d90f6632. - Bart Friedman: chair, Nominating and Corporate Governance Committee. Claim: alpha:claim:company:0b05be43-c1e7-40d4-a121-a3987ede577d:committee_appointment:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:1347145573b7699db28a2ab9f8f46f088d9f8c4f96b78888f655eff3d90f6632. - Kevin Fitzgerald: member, Nominating and Corporate Governance Committee. Claim: alpha:claim:company:0b05be43-c1e7-40d4-a121-a3987ede577d:committee_appointment:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:1347145573b7699db28a2ab9f8f46f088d9f8c4f96b78888f655eff3d90f6632. ## Security Listing - OVID (NASDAQ). Claim: alpha:claim:company:0b05be43-c1e7-40d4-a121-a3987ede577d:security_listing:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:cdbbb5a756987384df1ff64d8fbf70eef56c1183539d4ebc58373c3652c924dd. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:cdbbb5a756987384df1ff64d8fbf70eef56c1183539d4ebc58373c3652c924dd: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/ovid-therapeutics-inc). - alpha:projection-evidence:document:8df87dfa11d4b772a1feb4e92d0f8850aa4452ce8665367bfe06a0d3b7b76c52: [SEC DEF 14A 0001628280-26-027621](https://www.sec.gov/Archives/edgar/data/1636651/000162828026027621/ovid-20260427.htm). - alpha:projection-evidence:document:c85694de3ded3b66156d1756d8dc0a5c7f7292c72ac71db0f7c22a4adf2c37d6: [DEF 14A ovid-20260427.htm](https://www.sec.gov/Archives/edgar/data/1636651/000162828026027621/ovid-20260427.htm). - alpha:projection-evidence:1347145573b7699db28a2ab9f8f46f088d9f8c4f96b78888f655eff3d90f6632: [Audit Committee](https://www.sec.gov/Archives/edgar/data/1636651/000162828026027621/ovid-20260427.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/ovid-therapeutics-inc) - [Public Markdown](https://registry.alpha.ac/companies/ovid-therapeutics-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/ovid-therapeutics-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/ovid-therapeutics-inc?format=jsonld) - MCP resource: `alpha://companies/ovid-therapeutics-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-16T09:25:47.638422+00:00; recorded 2026-10-16T09:25:47.638422+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.